| 摘要 |
<p>The present invention is directed to [l,2,4]mazolo[4,3-b][l,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. (I)</p> |
| 申请人 |
INCYTE CORPORATION;ZHUO, JINCONG;ZHANG, COLIN;XU, MEIZHONG;QIAN, DING-QUAN;YAO, WENQING;JALLURI, RAVI KUMAR |
发明人 |
ZHUO, JINCONG;ZHANG, COLIN;XU, MEIZHONG;QIAN, DING-QUAN;YAO, WENQING;JALLURI, RAVI KUMAR |
